We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+18.18%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.12B
AUM Growth
+$507M
Cap. Flow
+$424M
Cap. Flow %
37.86%
Top 10 Hldgs %
69.37%
Holding
669
New
238
Increased
59
Reduced
66
Closed
278

Sector Composition

Rank Sector Weight
1 Financials 8.86%
2 Healthcare 4.92%
3 Technology 4.04%
4 Communication Services 3.4%
5 Industrials 2.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRUB
76
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$1.05M 0.09%
7,060
-1,591
-18% -$235K
CLF icon
77
Cleveland-Cliffs
CLF
$7.13B
$1.05M 0.09%
71,912
-171,293
-70% -$1.73M
ABBV icon
78
CALL
AbbVie
ABBV
$438B
$1.04M 0.09%
96,400
+56,700
+143% +$5.45M
ALXN
79
DELISTED
Alexion Pharmaceuticals
ALXN
$1.03M 0.09%
+6,593
New +$847K
VRTX icon
80
Vertex Pharmaceuticals
VRTX
$133B
$990K 0.09%
+4,190
New +$961K
TLRY icon
81
Tilray
TLRY
$602M
$969K 0.09%
+11,726
New +$855K
DBVT
82
DBV Technologies
DBVT
$897M
$964K 0.09%
+36,811
New +$815K
VYGG
83
DELISTED
Vy Global Growth
VYGG
$958K 0.09%
+91,961
New +$959K
SCVX
84
DELISTED
SCVX Corp.
SCVX
$949K 0.08%
+92,092
New +$934K
ANDAU
85
DELISTED
Andina Acquisition Corp. III Unit
ANDAU
$948K 0.08%
92,157
WKHS icon
86
CALL
Workhorse Group
WKHS
$34.5M
$946K 0.08%
+59
New +$3.84M
THCX
87
DELISTED
AXS Cannabis ETF
THCX
$938K 0.08%
7,500
CND.U
88
DELISTED
Concord Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
CND.U
$927K 0.08%
+89,888
New +$917K
LAZRW
89
DELISTED
Luminar Technologies, Inc. Warrant
LAZRW
$894K 0.08%
+52,079
New +$684K
NHICU
90
DELISTED
NewHold Investment Corp. Unit
NHICU
$880K 0.08%
+84,258
New +$859K
ONC
91
CALL
BeOne Medicines Ltd
ONC
$40.6B
$847K 0.08%
13,900
+8,400
+153% +$2.31M
GBT
92
DELISTED
Global Blood Therapeutics, Inc.
GBT
$841K 0.08%
+19,416
New +$957K
HTT
93
PUT
High Templar Tech Ltd
HTT
$394M
$815K 0.07%
304,800
TLRY icon
94
PUT
Tilray
TLRY
$602M
$808K 0.07%
51,620
-65,240
-56% -$4.76M
LAZR
95
PUT
DELISTED
Luminar Technologies
LAZR
$797K 0.07%
+2,000
New +$531K
HLMN icon
96
Hillman Solutions
HLMN
$1.77B
$786K 0.07%
+75,000
New +$759K
ALL icon
97
Allstate
ALL
$68.2B
$784K 0.07%
+7,129
New +$701K
NAV
98
CALL
DELISTED
Navistar International
NAV
$746K 0.07%
53,300
-111,300
-68% -$4.85M
BFT.U
99
DELISTED
Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an
BFT.U
$698K 0.06%
+41,046
New +$489K
BAC icon
100
CALL
Bank of America
BAC
$447B
$695K 0.06%
312,200
+272,200
+681% +$7.3M

Similar funds

Cowen and Company's Q4 2020 Portfolio in Review

As of Q4 2020, Cowen and Company held 669 positions worth $1.12B, up 83% from $613M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Cowen and Company deployed $424M of net new capital in Q4 2020, opening 238 new positions and adding to 59 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 825,000 shares worth $114M.

By sector, the portfolio is most concentrated in Financials at 8.9% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was McDonald's, an estimated $10.2M trimmed.

  • Cowen and Company's largest Q4 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 825,000 shares worth $114M.
  • Cowen and Company added most to Invesco QQQ Trust in Q4 2020, an estimated $68.6M increase.
  • Cowen and Company's biggest Q4 2020 reduction was McDonald's, cutting an estimated $10.2M.
  • Cowen and Company fully exited Nikola Corporation Common Stock in Q4 2020, selling an estimated $40M.
  • Cowen and Company's ten largest holdings make up 69% of its $1.12B portfolio in Q4 2020.
  • Cowen and Company opened 238 new positions and closed 278 in Q4 2020.
  • Cowen and Company's portfolio value rose 83% quarter-over-quarter to $1.12B.

Based on Cowen and Company's 13F filing for Q4 2020, filed 8 Feb 2021.